Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leichter, S. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leichter, S. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 19:148-150, 2001
© American Diabetes Association ®, Inc., 2001


The Business of Diabetes

Cost and Reimbursement as Determinants of the Quality of Diabetes Care: II. Indirect Influences on Cost

Steven B. Leichter, MD, FACP, FACE


    Introduction
 
Author’s note: This is the second of a three-part series on the cost and reimbursement issues that influence the delivery of diabetes care.

As discussed in the first article of this series,1 the complexity of adequate diabetes care delivery that meets guidelines for care2 renders the direct costs of care higher than those for other forms of contemplative primary or specialty care. For any level of reimbursement, this means that the margin of profit is relatively slim.

However, any economic activity, whether rendering a product or a service, also carries with it a set of indirect costs. These costs are inherent in conducting the economic activity; however, they are neither essential nor obviously related to the process of delivering the product or service itself. They are ancillary costs, which are unavoidable. The actions associated with them do not enhance either the cash flow or the profitability of the economic endeavor. Nevertheless, they are costs that must be met as conditions for the constructive economic activity to occur.

In diabetes care delivery, these indirect costs are quite significant and, relative to other care delivery activities, fairly numerous. Without careful attention and control, they represent a substantial part of the risk of loss caused by excessive expenditures versus revenue in this area of medicine.


    The Indirect Costs of Diabetes Care
 
In general, there are four categories of indirect costs related to diabetes care. They are:

  1. costs related to guidelines for care and office operation;
  2. costs of documentation for issues associated with the rendering of care but not directly involved in it;
  3. costs related to arrangements for services and supplies to patients;
  4. costs of communication for issues not pertinent to the direct care of the patient.

For any given patient, many of these costs are reasonable and constitute expected costs of providing care. However, the demand for these services . . . [Full Text of this Article]


    1. Costs of Guidelines
 

    2. Costs of Documentation
 

    3. Costs Related to the Provision of Services and Supplies to Patients
 

    4. Costs of Communication for Unrelated Issues
 

    Controlling Indirect Costs
 

    Footnotes
 

    REFERENCES
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. DiabetesHome page
S. B. Leichter
Third-Party Reimbursement: Now Comes the Really Difficult Part
Clin. Diabetes, October 1, 2003; 21(4): 181 - 182.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
S. B. Leichter
Cost and Reimbursement as Determinants of the Quality of Diabetes Care: 3. Reimbursement Determinants
Clin. Diabetes, January 1, 2002; 20(1): 43 - 44.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.